St. Luke's Cancer Center, Clinical Trial, 3rd floor, 1600 St. Luke's Blvd. — Easton, Pennsylvania

St. Luke's Cancer Center, Clinical Trial, 3rd floor, 1600 St. Luke's Blvd. is a clinical research site located in Easton, Pennsylvania, United States 18045.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

St. Luke's Cancer Center, Clinical Trial, 3rd floor, 1600 St. Luke's Blvd. has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID.

Sponsors: Philogen S.p.A..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's Cancer Center, Clinical Trial, 3rd floor, 1600 St. Luke's Blvd.?

St. Luke's Cancer Center, Clinical Trial, 3rd floor, 1600 St. Luke's Blvd. has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's Cancer Center, Clinical Trial, 3rd floor, 1600 St. Luke's Blvd. conducted?

St. Luke's Cancer Center, Clinical Trial, 3rd floor, 1600 St. Luke's Blvd. has 1 clinical trials on record, with 1 currently active. Their work covers Melanoma Stage IIIB, Melanoma Stage IIIC, Melanoma Stage IIID.

Is St. Luke's Cancer Center, Clinical Trial, 3rd floor, 1600 St. Luke's Blvd. accredited by Crixeo Health?

St. Luke's Cancer Center, Clinical Trial, 3rd floor, 1600 St. Luke's Blvd. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Luke's Cancer Center, Clinical Trial, 3rd floor, 1600 St. Luke's Blvd.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.